First in-human images of new hope treatment for poor-prognosis prostate cancer
In a world first, supported by National Imaging Facility, Australian researchers have imaged and measured the uptake of a promising new prostate cancer therapy drug developed by Australian start-up AdvanCell, which was recently administered to its first patient in a clinical trial.